Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

QGEN

Qiagen NV

Sep 12 • 04:00PM ET

45.28

-0.78 -1.69 %

Healthcare • Diagnostics & Research • Netherlands • NYSE

Peers: TMO DHR ILMN A BIO TECH WAT MTD HOLX BRKR

| Held by: IWR COWG IWD IWS DFIS IWB PBE VONV JQUA BBH

Scroll to Statements

Index	-	P/E	26.50	EPS (ttm)	1.71	Insider Own	0.74%	Shs Outstand	216.83M	Perf Week	-4.77%
Market Cap	9.81B	Forward P/E	17.88	EPS next Y	2.53	Insider Trans	0.00%	Shs Float	214.96M	Perf Month	-8.02%
Enterprise Value	10.30B	PEG	3.67	EPS next Q	0.59	Inst Own	77.88%	Short Float	3.13%	Perf Quarter	-4.45%
Income	373.39M	P/S	4.81	EPS this Y	4.73%	Inst Trans	0.37%	Short Ratio	4.66	Perf Half Y	16.40%
Sales	2.04B	P/B	2.80	EPS next Y	7.97%	ROA	6.55%	Short Interest	6.72M	Perf YTD	1.70%
Book/sh	16.17	P/C	10.28	EPS next 5Y	7.22%	ROE	10.81%	52W High	51.88 -12.71%	Perf Year	-1.34%
Cash/sh	4.40	P/FCF	19.67	EPS past 3/5Y	-45.34% -	ROIC	8.50%	52W Low	37.63 20.33%	Perf 3Y	-1.82%
Dividend Est.	0.16 (0.35%)	EV/EBITDA	14.20	Sales past 3/5Y	-4.22% 5.32%	Gross Margin	63.23%	Volatility	1.72% 1.47%	Perf 5Y	-4.98%
Dividend TTM	0.25 (0.55%)	EV/Sales	5.05	EPS Y/Y TTM	412.41%	Oper. Margin	26.29%	ATR (14)	0.84	Perf 10Y	72.54%
Dividend Ex-Date	Jul 02, 2025	Quick Ratio	1.35	Sales Y/Y TTM	5.15%	Profit Margin	18.30%	RSI (14)	33.23	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	1.61	EPS Q/Q	151.89%	SMA20	-5.06%	Beta	0.67	Target Price	52.51
Payout	0.00%	Debt/Eq	0.41	Sales Q/Q	7.49%	SMA50	-6.64%	Rel Volume	0.68	Prev Close	46.06
Employees	5765	LT Debt/Eq	0.25	Earnings	Aug 05 AMC	SMA200	2.04%	Avg Volume	1.44M	Price	45.28
IPO	Jun 28, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.38% 1.82%	Trades		Volume	974,679	Change	-1.69%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-24-25	Initiated	Barclays	Overweight	$55
Apr-04-25	Downgrade	Redburn Atlantic	Buy → Neutral
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral	$52 → $42
Jan-06-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$48
Dec-10-24	Upgrade	Jefferies	Hold → Buy	$42.50 → $54
Oct-17-24	Downgrade	HSBC Securities	Buy → Hold	$49
Jun-27-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$50
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$44
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Dec-07-23	Upgrade	Goldman	Neutral → Buy	$50
Sep-12-23	Initiated	Robert W. Baird	Outperform	$50
May-23-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-18-22	Initiated	Morgan Stanley	Equal-Weight
Jan-18-22	Upgrade	DZ Bank	Hold → Buy
Oct-15-21	Resumed	Cowen	Market Perform	$55
Oct-14-21	Initiated	Redburn	Buy
Jul-14-21	Downgrade	Kepler	Buy → Hold	$49.53
Jun-03-21	Initiated	Goldman	Neutral	$52
Oct-06-20	Resumed	BofA Securities	Buy	$59
Sep-28-20	Upgrade	Kepler	Hold → Buy

Show Previous Ratings

Sep-11-25 11:13AM	Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing (Insider Monkey)
Sep-10-25 04:05PM	QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio (Business Wire)
10:06AM	Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds (Zacks)
Sep-03-25 09:18AM	QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise (Zacks)
Sep-02-25 01:30AM	QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing (Business Wire)
08:06AM	Loading…
Aug-29-25 08:06AM	The Role of M&A in Hologic's Growth Story: Are More Deals in Sight? (Zacks)
Aug-28-25 07:38PM	Analyst Report: Qiagen N.V. (Morningstar Research)
05:08PM	QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds (Business Wire)
12:11PM	QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds (Business Wire)
02:05AM	QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds (Business Wire)
Aug-20-25 10:18AM	INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold? (Zacks)
Aug-11-25 09:15AM	Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention (Zacks)
Aug-06-25 06:51AM	Analyst Report: Qiagen N.V. (Morningstar Research)
Aug-05-25 07:00PM	Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
06:20PM	Qiagen (QGEN) Matches Q2 Earnings Estimates (Zacks)
05:23PM	Loading…
05:23PM	Qiagen: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability (Business Wire)
09:24AM	What to Expect from Qiagen NV (QGEN) Q2 2025 Earnings (GuruFocus.com)
Jul-28-25 09:05AM	CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains? (Zacks)
Jul-23-25 07:33PM	Analyst Report: Qiagen N.V. (Morningstar Research)
09:45AM	Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term (Zacks)
Jul-22-25 04:05PM	QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels (Business Wire)
08:32AM	Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report? (Zacks)
Jul-14-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-10-25 11:40AM	QGEN or EXAS: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-08-25 08:31AM	Is Hologic Stock's Low Valuation an Opportunity or a Value Trap? (Zacks)
05:44AM	QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast (Business Wire)
Jul-07-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-03-25 09:18AM	Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays (Insider Monkey)
09:33AM	Loading…
Jul-01-25 09:33AM	Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock? (Zacks)
Jun-26-25 01:16PM	QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board (Business Wire)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jun-24-25 11:40AM	QGEN vs. EXAS: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Here's Why Qiagen (QGEN) is a Strong Value Stock (Zacks)
Jun-23-25 09:55AM	Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Jun-20-25 09:45AM	Here's Why Qiagen (QGEN) is a Strong Growth Stock (Zacks)
Jun-19-25 08:35AM	QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock (Zacks)
Jun-18-25 04:05PM	QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership (Business Wire)
Jun-17-25 12:08PM	Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics (Zacks)
Jun-16-25 08:27AM	QGEN Stock Rises in After Market Following Partnership With Incyte (Zacks)
07:06AM	Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms (Medical Device Network)
Jun-15-25 04:00AM	QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) (Business Wire)
Jun-13-25 12:13PM	Should You Add QIAGEN Stock to Your Portfolio for Now? (Zacks)
Jun-11-25 08:29AM	Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate? (Zacks)
Jun-09-25 09:50AM	Here's Why Qiagen (QGEN) is a Strong Momentum Stock (Zacks)
Jun-06-25 11:31AM	Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue? (Zacks)
Jun-04-25 09:45AM	Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term (Zacks)
Jun-03-25 09:40AM	Here's Why Qiagen (QGEN) is a Strong Value Stock (Zacks)
08:08AM	QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances (Zacks)
Jun-02-25 02:05PM	QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships (Business Wire)
01:00PM	Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma (PR Newswire)
May-25-25 07:32AM	Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research (Insider Monkey)
May-23-25 08:41AM	QGEN Stock Might Gain Following New Partnership With ID Solutions (Zacks)
05:32AM	Qiagen and ID Solutions collaborate on dPCR assays for oncology research (Medical Device Network)
May-22-25 04:05PM	QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions (Business Wire)
May-19-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
May-16-25 09:50AM	Here's Why Qiagen (QGEN) is a Strong Momentum Stock (Zacks)
May-15-25 09:40AM	Here's Why Qiagen (QGEN) is a Strong Value Stock (Zacks)
May-13-25 07:07AM	QIAGEN Stock Gains Following the Acquisition of Genoox (Zacks)
May-12-25 04:05PM	QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software (Business Wire)
May-08-25 09:37AM	Analyst Report: Qiagen N.V. (Morningstar Research)
06:52AM	QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up (Zacks)
May-07-25 07:30PM	Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings (Zacks)
06:15PM	Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates (Zacks)
05:10PM	Qiagen: Q1 Earnings Snapshot (Associated Press Finance)
04:20PM	QIAGEN announces plans for transition in leadership of Supervisory Board (Business Wire)
04:05PM	QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase (Business Wire)
09:36AM	Qiagen NV (QGEN) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:45AM	QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting (Business Wire)
May-06-25 09:15AM	Stay Ahead of the Game With Qiagen (QGEN) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
May-02-25 11:40AM	QGEN or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
May-01-25 05:35PM	Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
10:01AM	Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Apr-30-25 10:01AM	Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-29-25 04:05PM	QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control (Business Wire)
09:40AM	Why Qiagen (QGEN) is a Top Value Stock for the Long-Term (Zacks)
Apr-22-25 04:05PM	QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025 (Business Wire)
Apr-16-25 09:50AM	Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term (Zacks)
Apr-15-25 01:30AM	QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation (Business Wire)
Apr-10-25 01:31PM	Analyst Report: Qiagen N.V. (Morningstar Research)
09:53AM	Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock? (Zacks)
Apr-08-25 11:22AM	QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast (Business Wire)
Apr-07-25 09:28AM	Analyst Report: Qiagen N.V. (Morningstar Research) +5.36%
Apr-06-25 02:28PM	QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook (Business Wire)
Apr-01-25 01:30AM	QIAGEN Launches QIAprep&amp Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts (Business Wire)
Mar-31-25 10:00AM	Bio-Techne Opens New Customer Experience Centre in Germany (Zacks)
06:00AM	QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results (Business Wire)
Mar-19-25 09:57AM	HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip? (Zacks)
Mar-07-25 11:31AM	Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound? (Zacks)
07:31AM	FDA clears Qiagens QIAstat-Dx Gastrointestinal Panel 2 Mini B (Medical Device Network)
Mar-06-25 01:00AM	QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio (Business Wire)
Mar-03-25 06:48PM	Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now (Insider Monkey)
01:00AM	QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing (Business Wire)
Feb-23-25 07:00AM	2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62% (Motley Fool)
Feb-13-25 04:05PM	QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region (Business Wire)
Feb-06-25 11:22AM	Analyst Report: Qiagen N.V. (Morningstar Research)
Feb-05-25 06:00PM	Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Qiagen (QGEN) Q4 Earnings Lag Estimates (Zacks)
04:59PM	Qiagen: Q4 Earnings Snapshot (Associated Press Finance)

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Thierry Bernard	Officer	Aug 15 '25	Proposed Sale	48.80	25,000	1,220,000	Aug 15 04:52 PM
ROLAND SACKERS	Officer	Aug 15 '25	Proposed Sale	49.21	31,423	1,546,257	Aug 15 04:26 PM
ROLAND SACKERS	Officer	Aug 14 '25	Proposed Sale	49.00	18,577	910,286	Aug 14 06:11 PM
ROLAND SACKERS	Officer	Aug 13 '25	Proposed Sale	49.13	50,000	2,456,435	Aug 13 06:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QGEN

Qiagen NV

Upgrade your FINVIZ experience